 Cerevel Therapeutics Holdings, Inc. NASDAQ:CERE Q3 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Matt Calistri - Vice President of Corporate Strategy and Investor Relations Anthony Coles - Chairperson and Chief Executive Officer Raymond Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Mark Bodenrader - Interim Chief Financial Officer Abraham Ceesay - President Conference Call Participants Umer Raffat - Evercore Michael Yee - Jefferies Paul Matteis - Stifel Tazeen Ahmad - Bank of America Max Skor - Morgan Stanley Mohit Bansal - Wells Fargo Rob Palermo - Goldman Sachs Charles Duncan - Cantor Fitzgerad Douglas Tsao - H.C. Wainwright Operator Good morning, and welcome to the Cerevel Therapeutics Third Quarter 2022 Financial Results Conference Call. 